Renaissance Technologies’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.2K | Buy |
+26,300
| New | +$94.2K | ﹤0.01% | 3306 |
|
|
2024
Q1 | – | Sell |
-3,823
| Closed | -$29K | – | 3852 |
|
|
2023
Q4 | $29K | Buy |
3,823
+1,600
| +72% | +$12.1K | ﹤0.01% | 3535 |
|
|
2023
Q3 | $16K | Sell |
2,223
-850
| -28% | -$6.12K | ﹤0.01% | 3546 |
|
|
2023
Q2 | $29K | Buy |
3,073
+760
| +33% | +$7.17K | ﹤0.01% | 3706 |
|
|
2023
Q1 | $38K | Buy |
2,313
+773
| +50% | +$12.7K | ﹤0.01% | 3714 |
|
|
2022
Q4 | $41K | Buy |
+1,540
| New | +$41K | ﹤0.01% | 3835 |
|
|
2022
Q3 | – | Sell |
-2,157
| Closed | -$193K | – | 4166 |
|
|
2022
Q2 | $193K | Sell |
2,157
-4,053
| -65% | -$363K | ﹤0.01% | 3666 |
|
|
2022
Q1 | $537K | Sell |
6,210
-4,013
| -39% | -$347K | ﹤0.01% | 3140 |
|
|
2021
Q4 | $935K | Buy |
10,223
+7,400
| +262% | +$677K | ﹤0.01% | 2696 |
|
|
2021
Q3 | $571K | Buy |
+2,823
| New | +$571K | ﹤0.01% | 2838 |
|